pharmaceuticals

The guidelines took years to finalize, but while regulators were drafting them, a new trend emerged: online pharmaceutical influencers with little government oversight.

Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts.

A woman ended up stranded in the hospital because CVS stopped providing the IV nutrition she needs to survive at home. Without it, she’d starve.

The Big Three pharmacy benefit managers say they return nearly all the rebates they get from drugmakers to the employers and insurers who hire them. But most employers seem to doubt that.

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.

The FDA considers plants that have gone more than five years without an inspection to be a significant risk. Officials say the work has been hampered by difficulties recruiting and retaining inspectors.

The school district is self-insured, meaning it foots the bill for the health care costs of employees. As many as 3,500 employees may be affected by insulin price increases over the past 20 years.

As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark — home of Ozempic maker Novo Nordisk — has limited coverage of the drug after cost overruns “emptied all the money boxes in the entire public health system.”

A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations — could leave the country with a patchwork of disparate health regulations.

The failed dissolution of Glenmark Pharmaceuticals' extended-release capsules may cause high potassium levels, also known as hyperkalemia, which can result in irregular heart beat that can lead to cardiac arrest.